Abstract:Purpose Carbon ion radiotherapy (CIRT) relies on relative biological effectiveness (RBE)‐weighted dose calculations. Japanese clinics predominantly use the microdosimetric kinetic model (MKM), while European centers utilize the local effect model (LEM). Despite both models estimating RBE‐distributions in tissue, their physical and mathematical assumptions differ, leading to significant disparities in RBE‐weighted doses. Several European clinics adopted Japanese treatment schedules, necessitating adjustments in dose prescriptions and organ at risk (OAR) constraints. In the context of these two clinically used standards for RBE‐weighted dose estimation, the objective of this study was to highlight specific scenarios for which the translations between models diverge, as shortcomings between them can influence clinical decisions. Methods Our aim was to discuss planning strategies minimizing those discrepancies, ultimately striving for more accurate and robust treatments. Evaluations were conducted in a virtual water phantom and patient CT‐geometry, optimizing LEM RBE‐weighted dose first and recomputing MKM thereafter. Dose‐averaged linear energy transfer (LETd) distributions were also assessed. Results Results demonstrate how various parameters influence LEM/MKM translation. Similar LEM‐dose distributions lead to markedly different MKM‐dose distributions and variations in LETd. Generally, a homogeneous LEM RBE‐weighted dose aligns with lower MKM values in most of the target volume. Nevertheless, paradoxical MKM hotspots may emerge (at the end of the range), potentially influencing clinical outcomes. Therefore, translation between models requires great caution. Conclusions Understanding the relationship between these two clinical standards enables combining European and Japanese based experiences. The implementation of optimal planning strategies ensures the safety and acceptability of the clinical plan for both models and therefore enhances plan robustness from the RBE‐weighted dose and LETd distribution point of view. This study emphasizes the importance of optimal planning strategies and the need for comprehensive CIRT plan quality assessment tools. In situations where simultaneous LEM and MKM computation capabilities are lacking, it can provide guidance in plan design, ultimately contributing to enhanced CIRT outcomes.

Macro-and Micro-scale Dose Simulation of Heavy Ion Relative Biological Effectiveness

A Modified Microdosimetric Kinetic Model for Relative Biological Effectiveness Calculation

Mechanistic modelling of relative biological effectiveness of carbon ion beams and comparison with experiments

Study on microdosimetry for carbon ion radiotherapy

Modeling the Biophysical Effects in a Carbon Beam Delivery Line using Monte Carlo Simulation

Primary study of the relative and compound biological effectiveness model for boron neutron capture therapy based on nanodosimetry

RBE and related modeling in carbon-ion therapy

Validation of the relative biological effectiveness of active-energy scanning carbon-ion radiotherapy on a commercial treatment planning system with a microdosimetic kinetic model

A mathematical approach to aspects of LET, micro- and nano-dosimetry in radiation therapy with photons and charged particles

A methodology to abridge microdosimetric distributions without a significant loss of the spectral information needed for the RBE computation in carbon ion therapy

Microdosimetric Analysis for Boron Neutron Capture Therapy via Monte Carlo Track Structure Simulation with Modified Lithium Cross-sections

Incorporating boron distribution variations in microdosimetric kinetic model-based relative biological effectiveness calculations for boron neutron capture therapy

β-delayed multiple-particle emitters minibeam radiation therapy: first dosimetric evaluation with Monte Carlo simulations

Calculation of the DNA damage yield and relative biological effectiveness in boron neutron capture therapy via the Monte Carlo track structure simulation

Determination of RBE of 450 MeV/nucleon carbon ions using the micronucleus test and survival of mice after irradiation in different regions of the Bragg curve

LET‐based approximation of the microdosimetric kinetic model for proton radiotherapy

Radiobiological issues in prospective carbon ion therapy trials

Ionization detail parameters and cluster dose: A mathematical model for selection of nanodosimetric quantities for use in treatment planning in charged particle radiotherapy

A Monte Carlo study of different LET definitions and calculation parameters for proton beam therapy

The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models